Categories 2024 Press Releases The Board Of Directors Approves The Consolidated Interim Financial Report As Of 30th June 2024 Post author By Antonio Buono Post date 27 September 2024 The Board Of Directors Approves The Consolidated Interim Financial Report As Of 30th June 2024
Categories 2024 Press Releases The Board of Directors Approves the Draft Financial Statements and Consolidated Financial Statements as at 31 December 2023 Post author By Antonio Buono Post date 29 March 2024 The Board of Directors Approves the Draft Financial Statements and Consolidated Financial Statements as at 31 December 2023
Categories 2024 GROUP REVENUES 2023 EQUATED TO €71.2 MILLION (+8% YoY) DRIVEN BY ONLINE RETAIL CHANNEL (+28% YoY) Post author By Giovanni De Stefano Post date 16 February 2024 Group Revenues 2023 Equated To €71.2 Million (+8% Yoy) Driven By Online Retail Channel (+28% Yoy)
Categories 2024 Press Releases Opening of the Warrant Exercise Period Post author By Antonio Buono Post date 23 January 2024 Opening of the Warrant Exercise Period
Farmacosmo InvestorsFarmacosmo Investors